Table 1 Percentuals of answers to the proposed questions
From: Algorithm for the treatment of type 2 diabetes: a position statement of Brazilian Diabetes Society
ANSWERES' PERCENTAGES | |||
|---|---|---|---|
PROPOSED QUESTIONS | Yes | No | Others |
1. Have you read the Treatment of Type 2 Diabetes algorithm proposed by ADA/EASD? | 90 | 10 | - |
2. Were you aware that the document expresses the opinion of a few authors and not of the entities involved? | 77 | 23 | - |
3. Do you intend to adopt the stages and steps suggested by this algorithm in your practice? | 51 | 49 | - |
4. Do you think that rosiglitazone-associated adverse events have been ratified in the medical literature of excellence? | 36 | 64 | - |
5. Do you think that the cardiovascular protection assigned topioglitazone in that Position Statement is real? | 34 | 66 | - |
6. Do you think that glitazone-associated adverse events (bone fracture and cardiovascular events) are effects pertaining to this therapeutical class? | 49 | 21 | 30 |
7. Do you think that only GLP-1 analogs should be included in diabetes treatment excluding DPP-4 inhibitors? | 13 | 69 | 18 |
8. Do you think that BDS' members have the expertise and the ability of criticism to issue a Position Statement about this Algorithm? | 87 | 4 | 9 |